# VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

> **NCT07375212** · PHASE4 · WITHDRAWN · sponsor: **Prisma Health-Upstate**

## Conditions studied

- Heart Failure Congestive

## Interventions

- **DRUG:** Bumetanide, intranasal 4mg

## Key facts

- **NCT ID:** NCT07375212
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01-21
- **Primary completion:** 2026-01-21
- **Final completion:** 2026-01-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in Sponsor
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375212, "VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07375212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*